鼻病毒感染对健康的影响研究
摘要
关键词
参考
Principi N., Zampiero A., Gambino M., Scala A., Senatore L., Lelii M., Ascolese B., Pelucchi C., Esposito S. Prospective evaluation of rhinovirus infection in healthy young children. J. Clin. Virol. 2015;66:83–89.
Fine J., Bray-Aschenbrenner A., Williams H., Buchanan P., Werner J. The Resource Burden of Infections with Rhinovirus/Enterovirus, Influenza, and Respiratory Syncytial Virus in Children. Clin. Pediatr. 2019;58:177–184.
Greenberg S.B. Respiratory Consequences of Rhinovirus Infection. Arch. Intern. Med. 2003;163:278–284. doi: 10.1001/archinte.163.3.278.
王擎, 罗明, 王雪, 黄芳, 龚成. 人鼻病毒的研究进展. 中华实验和临床病毒学杂志. 2023; 37: 216-221.
Winther B., McCue K., Ashe K., Rubino J., Hendley J. Rhinovirus contamination of surfaces in homes of adults with natural colds: Transfer of virus to fingertips during normal daily activities. J. Med. Virol. 2011;83:906–909.
Liu L., Li Y., Nielsen P.V., Wei J., Jensen R.L. Short-range airborne transmission of expiratory droplets between two people. Indoor Air. 2016;27:452–462.
Chen W.J., Arnold J.C., Fairchok M.P., Danaher P.J., McDonough E.A., Blair P.J., Garcia J., Halsey E.S., Schofield C., Ottolini M., et al. Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: Rhinovirus among adults and children. J. Clin. Virol. 2015;64:74–82.
常颖, 黄光举, 张慧玉, 李娟, 徐静. 儿童呼吸系统鼻病毒感染流行特征分析. 2024; 19:312-315.
Hayden F.G. Rhinovirus and the lower respiratory tract. Rev. Med. Virol. 2004;14:17–31. doi: 10.1002/rmv.406.
Walker E., Ison M.G. Respiratory viral infections among hospitalized adults: Experience of a single tertiary healthcare hospital. Influ. Other Respir. Viruses. 2014;8:282–292.
程利红, 刘莉, 梁胜楠, 钱璐, 周璞, 张金忠, 杜银菊. 2016～2018年聊城市部分儿童社区获得性肺炎患者的病原体分布及耐药性分析. 预防医学论坛. 2021; 27: 410-412,419.
Schilder A.G., Chonmaitree T., Cripps A.W., Rosenfeld R.M., Casselbrant M.L., Haggard M.P., Venekamp R.P. Otitis media. Nat. Rev. Dis. Primers. 2016;2:16063.
Adam D.C., Chen X., Scotch M., MacIntyre C.R., Dwyer D., Kok J. The Molecular Epidemiology and Clinical Phylogenetics of Rhinoviruses Among Paediatric Cases in Sydney, Australia. Int. J. Infect. Dis. 2021;110:69–74.
Golke P., Hönemann M., Bergs S., Liebert U.G. Human Rhinoviruses in Adult Patients in a Tertiary Care Hospital in Germany: Molecular Epidemiology and Clinical Significance. Viruses. 2021;13:2027.
Li W., Yu B., Zhou J., Wang Y., Xue B., Pan J., Ran Y., Yang X., Yang F., Li H. Genetic diversity and epidemiology of human rhinovirus among children with severe acute respiratory tract infection in Guangzhou, China. Virol. J. 2021;18:174.
Choi T., Devries M., Bacharier L.B., Busse W., Camargo C.A., Jr., Cohen R., Demuri G.P., Evans M.D., Fitzpatrick A.M., Gergen P.J., et al. Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection. Am. J. Respir. Crit. Care Med. 2021;203:822–830.
Clark T.W., Ewings S., Medina M.-J., Batham S., Curran M.D., Parmar S., Nicholson K.G. Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illness. J. Infect. 2016;73:598–606.
Xiao Q., Zheng S., Zhou L., Ren L., Xie X., Deng Y., Tian D., Zhao Y., Fu Z., Li T., et al. Impact of Human Rhinovirus Types and Viral Load on the Severity of Illness in Hospitalized Children with Lower Respiratory Tract Infections. Pediatr. Infect. Dis. J. 2015;34:1187–1192.
Granados A., Peci A., McGeer A., Gubbay J.B. Influenza and rhinovirus viral load and disease severity in upper respiratory tract infections. J. Clin. Virol. 2017;86:14–19.
Van der Linden L., Bruning A.H., Thomas X.V., Minnaar R.P., Rebers S.P., Schinkel J., de Jong M.D., Pajkrt D., Wolthers K.C. A molecular epidemiological perspective of rhinovirus types circulating in Amsterdam from 2007 to 2012. Clin. Microbiol. Infect. 2016;22:1002.e9–1002.e14.
Morobe J.M., Nyiro J.U., Brand S., Kamau E., Gicheru E., Eyase F., Otieno G.P., Munywoki P.K., Agoti C., Nokes J. Human rhinovirus spatial-temporal epidemiology in rural coastal Kenya, 2015-2016, observed through outpatient surveillance. Wellcome Open Res. 2019;3:128.
Lopes G.P., Amorim P.S., de Melo B.D.O., Maramaldo C.E.C., Bomfim M.R.Q., Neto L.G.L., Alves M.S., Silva F.B., Soeiro-Pereira P.V., Falcai A. Identification and seasonality of rhinovirus and respiratory syncytial virus in asthmatic children in tropical climate. Biosci. Rep. 2020;40:BSR20200634.
Vittucci A.C., Piccioni L., Coltella L., Ciarlitto C., Antilici L., Bozzola E., Midulla F., Palma P., Perno C.F., Villani A. The Disappearance of Respiratory Viruses in Children during the COVID-19 Pandemic. Int. J. Environ. Res. Public Health. 2021;18:9550.
Mansuy J., Bourcier M., Trémeaux P., Dimeglio C., Izopet J. COVID-19 pandemic period, where are the seasonal viruses? J. Med. Virol. 2021;93:4097–4098.
Redlberger-Fritz M., Kundi M., Aberle S.W., Puchhammer-Stockl E. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J. Clin. Virol. 2021;137:104795.
Girkin J., Loo S.-L., Esneau C., Maltby S., Mercuri F., Chua B., Reid A.T., Veerati P.C., Grainge C.L., Wark P.A., et al. TLR2-mediated innate immune priming boosts lung anti-viral immunity. Eur. Respir. J. 2021;58:2001584.
Glanville N., Johnston S.L. Challenges in developing a cross-serotype rhinovirus vaccine. Curr. Opin. Virol. 2015;11:83–88.
Lee S., Nguyen M.T., Currier M.G., Jenkins J.B., Strobert E.A., Kajon A.E., Madan-Lala R., Bochkov Y.A., Gern J.E., Roy K., et al. A polyvalent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques. Nat. Commun. 2016;7:12838.
Hayden F.G., Herrington D.T., Coats T.L., Kim K., Cooper E.C., Villano S.A., Liu S., Hudson S., Pevear D.C., Collett M., et al. Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials. Clin. Infect. Dis. 2003;36:1523–1532.
Lanko K., Sun L., Froeyen M., Leyssen P., Delang L., Mirabelli C., Neyts J. Comparative analysis of the molecular mechanism of resistance to vapendavir across a panel of picornavirus species. Antivir. Res. 2021;195:105177
Mello C., Aguayo E., Rodriguez M., Lee G., Jordan R., Cihlar T., Birkus G. Multiple Classes of Antiviral Agents ExhibitIn VitroActivity against Human Rhinovirus Type C. Antimicrob. Agents Chemother. 2013;58:1546–1555.
Djukanovic R., Harrison T., Johnston S.L., Gabbay F., Wark P., Thomson N.C., Niven R., Singh D., Reddel H.J., Davies D.E., et al. The effect of inhaled IFN-beta on worsening of asthma symptoms caused by viral infections. A randomized trial. Am. J. Respir. Crit. Care Med. 2014;190:145–154.
Proud P.C., Tsitoura D., Watson R.J., Chua B.Y., Aram M.J., Bewley K.R., Cavell B.E., Cobb R., Dowall S., Ho C.M.K., et al. Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model. EBioMedicine. 2021;63:103153.
Busse W.W., Lemanske R.F., Jr., Gern J.E. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376:826–834.
Haddad-Boubaker S., Mefteh K., Mejri C., Bouaffsoun A., El Moussi A., Boutiba I., Mnif K., Slim A., Kechrid A., Smaoui H. High genotypic diversity of Rhinoviruses obtained from Tunisian children with severe acute respiratory infection. J. Infect. Dev. Ctries. 2021;15:726–735.
Ortega H., Nickle D., Carter L. Rhinovirus and asthma: Challenges and opportunities. Rev. Med. Virol. 2021;31:e2193.
Calvo C., Aguado I., García-García M.L., Ruiz-Chercoles E., Díaz-Martinez E., Albañil R.M., Campelo O., Olivas A., Muñóz-Gonzalez L., Pozo F., et al. Respiratory viral infections in a cohort of children during the first year of life and their role in the development of wheezing. An. Pediatr. Eng. Ed. 2017;87:104–110.
De Winter J.J., Bont L., Wilbrink B., van der Ent C.K., Smit H.A., Houben M.L. Rhinovirus wheezing illness in infancy is associated with medically attended third year wheezing in low risk infants: Results of a healthy birth cohort study. Immun. Inflamm. Dis. 2015;3:398–405.
Arden K.E., Faux C.E., O’Neill T., McErlean P., Nitsche A., Lambert S.B., Nissen M.D., Sloots T.P., Mackay I.M. Molecular characterization and distinguishing features of a novel human rhinovirus (HRV) C, HRVC-QCE, detected in children with fever, cough and wheeze during 2003. J. Clin. Virol. 2010;47:219–223.
Arden K.E., Chang A.B., Lambert S.B., Nissen M.D., Sloots T.P., Mackay I.M. Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J. Med. Virol. 2010;82:1458–1461.
Pierangeli A., Scagnolari C., Selvaggi C., Verzaro S., Spina M.T., Bresciani E., Antonelli G., Bertazzoni G. Rhinovirus frequently detected in elderly adults attending an emergency department. J. Med. Virol. 2011;83:2043–2047.
Hung I.F.N., Zhang A.J., Esposito S., Chan J.F.W., Zhu S.H.S., Zhang R., Chan T.-C., Chan K.-H., Yuen K.-Y. Unexpectedly Higher Morbidity and Mortality of Hospitalized Elderly Patients Associated with Rhinovirus Compared with Influenza Virus Respiratory Tract Infection. Int. J. Mol. Sci. 2017;18:259.
Lee N., Smith S., Zelyas N., Klarenbach S., Zapernick L., Bekking C., So H., Yip L., Tipples G., Taylor G., et al. Burden of noninfluenza respiratory viral infections in adults admitted to hospital: Analysis of a multiyear Canadian surveillance cohort from 2 centres. Can. Med. Assoc. J. 2021;193:E439–E446.
Tapparel C., Cordey S., Junier T., Farinelli L., Van Belle S., Soccal P.M., Aubert J.-D., Zdobnov E., Kaiser L. Rhinovirus Genome Variation during Chronic Upper and Lower Respiratory Tract Infections. PLoS ONE. 2011;6:e21163.
Refbacks
- 当前没有refback。